NanoVibronix, Inc. (NASDAQ:NAOV) Sees Significant Decrease in Short Interest

NanoVibronix, Inc. (NASDAQ:NAOV) was the recipient of a large decline in short interest in March. As of March 15th, there was short interest totalling 38,700 shares, a decline of 85.5% from the February 28th total of 267,600 shares. Based on an average daily trading volume, of 994,800 shares, the short-interest ratio is currently 0.0 days. Approximately 4.9% of the shares of the company are sold short.

NanoVibronix Price Performance

Shares of NASDAQ:NAOV traded down $0.47 during mid-day trading on Wednesday, reaching $3.88. 49,698 shares of the company traded hands, compared to its average volume of 269,409. NanoVibronix has a 52 week low of $1.92 and a 52 week high of $13.97. The firm has a market cap of $3.07 million, a PE ratio of -3.15 and a beta of 1.81. The company’s 50 day moving average price is $4.37 and its 200-day moving average price is $5.93.

NanoVibronix Company Profile

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.